NEVANAC

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NEVANAC contains one active pharmaceutical ingredient (API):

1 Nepafenac UNII 0J9L7J6V8C - NEPAFENAC

Nepafenac is a non-steroidal anti-inflammatory and analgesic prodrug. After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Amfenac inhibits the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production. Read about Nepafenac

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NEVANAC Eye drops, suspension	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01BC10	Nepafenac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500904901132312, 526514120079903
Country: CA	Health Products and Food Branch	Identifier(s): 02308983
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.817-08-07
Country: EE	Ravimiamet	Identifier(s): 1343001, 1614822
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07433001, 07433001IP, 107433002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 126949, 141063, 195092
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 155115, 345804, 375246
Country: HK	Department of Health Drug Office	Identifier(s): 57847
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7007
Country: IT	Agenzia del Farmaco	Identifier(s): 038813010, 038813022, 038813034
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319759Q1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1029815, 1074076, 1075476
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 329M2006
Country: NG	Registered Drug Product Database	Identifier(s): B4-3535
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106755
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100143311, 100201824
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64477001, W64478001
Country: SG	Health Sciences Authority	Identifier(s): 13759P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504710151, 8699504710205
Country: US	FDA, National Drug Code	Identifier(s): 0065-0002
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/15.4/1006